Tapewire

Nasdaq · USD

ALNY

ALNYLAM PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
3132
SEC CIK
0001178670
Parsed reports
483

Last 12 months

Inside the activity.

0 purchase rows · 279 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025031
Dec 202500
Jan 20260111
Feb 2026011
Mar 20260106
Apr 2026014
May 202600
Jun 202605
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 15, 2025 Filed May 19, 2025 20:17 UTC SaleCommon Stock 301 $275.63 $82,964.63
Disclosure

SEC source: 0001735276-25-000072 · edgardoc.xml · nonDerivative · entry 8

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,257

F1 · kind: This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025.

F8 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $275.11 to $276.05. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:17 UTC SaleCommon Stock 882 $273.75 $241,447.50
Disclosure

SEC source: 0001735276-25-000072 · edgardoc.xml · nonDerivative · entry 7

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,558

F1 · kind: This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025.

F7 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $273.61 to $274.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:17 UTC SaleCommon Stock 660 $273.16 $180,285.60
Disclosure

SEC source: 0001735276-25-000072 · edgardoc.xml · nonDerivative · entry 6

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,440

F1 · kind: This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025.

F6 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $272.60 to $273.59. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:17 UTC SaleCommon Stock 431 $271.68 $117,094.08
Disclosure

SEC source: 0001735276-25-000072 · edgardoc.xml · nonDerivative · entry 5

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,100

F1 · kind: This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025.

F5 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $271.44 to $272.10. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:17 UTC SaleCommon Stock 245 $269.79 $66,098.55
Disclosure

SEC source: 0001735276-25-000072 · edgardoc.xml · nonDerivative · entry 4

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,531

F1 · kind: This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025.

F4 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $269.53 to $269.88. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:17 UTC SaleCommon Stock 729 $268.56 $195,780.24
Disclosure

SEC source: 0001735276-25-000072 · edgardoc.xml · nonDerivative · entry 3

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,776

F1 · kind: This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025.

F3 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $268.28 to $269.16. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:17 UTC SaleCommon Stock 549 $267.14 $146,659.86
Disclosure

SEC source: 0001735276-25-000072 · edgardoc.xml · nonDerivative · entry 2

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,505

F1 · kind: This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025.

F2 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $266.87 to $267.72. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:17 UTC Exercise / conversionCommon Stock 11,250 $131.21 $1,476,112.50
Disclosure

SEC source: 0001735276-25-000072 · edgardoc.xml · nonDerivative · entry 1

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,054

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:05 UTC GrantStock Option (right to buy) · Derivative 1,558 $0.00 Strike: $258.35 $0.00
Disclosure

SEC source: 0001735276-25-000063 · edgardoc.xml · derivative · entry 3

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,558

Underlying: Common Stock · 1,558 shares

Expires 2035-05-08

F3 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:05 UTC GrantCommon Stock 775 $0.00 $0.00
Disclosure

SEC source: 0001735276-25-000063 · edgardoc.xml · nonDerivative · entry 1

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 911

F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:07 UTC GrantStock Option (right to buy) · Derivative 1,558 $0.00 Strike: $258.35 $0.00
Disclosure

SEC source: 0001735276-25-000068 · edgardoc.xml · derivative · entry 3

Ausiello Dennis A · CIK 0001381994 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,558

Underlying: Common Stock · 1,558 shares

Expires 2035-05-08

F3 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:07 UTC GrantCommon Stock 775 $0.00 $0.00
Disclosure

SEC source: 0001735276-25-000068 · edgardoc.xml · nonDerivative · entry 1

Ausiello Dennis A · CIK 0001381994 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 911

F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:07 UTC GrantStock Option (right to buy) · Derivative 1,558 $0.00 Strike: $258.35 $0.00
Disclosure

SEC source: 0001735276-25-000067 · edgardoc.xml · derivative · entry 3

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,558

Underlying: Common Stock · 1,558 shares

Expires 2035-05-08

F3 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:07 UTC GrantCommon Stock 775 $0.00 $0.00
Disclosure

SEC source: 0001735276-25-000067 · edgardoc.xml · nonDerivative · entry 1

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,804

F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:06 UTC GrantStock Option (right to buy) · Derivative 1,558 $0.00 Strike: $258.35 $0.00
Disclosure

SEC source: 0001735276-25-000066 · edgardoc.xml · derivative · entry 2

BRANDICOURT OLIVIER · CIK 0001508518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,558

Underlying: Common Stock · 1,558 shares

Expires 2035-05-08

F2 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:06 UTC GrantCommon Stock 775 $0.00 $0.00
Disclosure

SEC source: 0001735276-25-000066 · edgardoc.xml · nonDerivative · entry 1

BRANDICOURT OLIVIER · CIK 0001508518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 775

F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:06 UTC GrantStock Option (right to buy) · Derivative 1,558 $0.00 Strike: $258.35 $0.00
Disclosure

SEC source: 0001735276-25-000065 · edgardoc.xml · derivative · entry 2

HAMBURG MARGARET A · CIK 0001266917 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,558

Underlying: Common Stock · 1,558 shares

Expires 2035-05-08

F2 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:06 UTC GrantCommon Stock 775 $0.00 $0.00
Disclosure

SEC source: 0001735276-25-000065 · edgardoc.xml · nonDerivative · entry 1

HAMBURG MARGARET A · CIK 0001266917 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 911

F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:05 UTC GrantStock Option (right to buy) · Derivative 1,558 $0.00 Strike: $258.35 $0.00
Disclosure

SEC source: 0001735276-25-000064 · edgardoc.xml · derivative · entry 2

KELLOGG PETER N · CIK 0001226287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,558

Underlying: Common Stock · 1,558 shares

Expires 2035-05-08

F2 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:05 UTC GrantCommon Stock 775 $0.00 $0.00
Disclosure

SEC source: 0001735276-25-000064 · edgardoc.xml · nonDerivative · entry 1

KELLOGG PETER N · CIK 0001226287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 775

F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:04 UTC GrantStock Option (right to buy) · Derivative 1,558 $0.00 Strike: $258.35 $0.00
Disclosure

SEC source: 0001735276-25-000061 · edgardoc.xml · derivative · entry 2

SCHULMAN AMY W · CIK 0001438226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,558

Underlying: Common Stock · 1,558 shares

Expires 2035-05-08

F2 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:04 UTC GrantCommon Stock 775 $0.00 $0.00
Disclosure

SEC source: 0001735276-25-000061 · edgardoc.xml · nonDerivative · entry 1

SCHULMAN AMY W · CIK 0001438226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,961

F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:05 UTC GrantStock Option (right to buy) · Derivative 1,558 $0.00 Strike: $258.35 $0.00
Disclosure

SEC source: 0001735276-25-000062 · edgardoc.xml · derivative · entry 5

Reitan Colleen F · CIK 0001740730 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,558

Underlying: Common Stock · 1,558 shares

Expires 2035-05-08

F2 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:05 UTC GrantCommon Stock 775 $0.00 $0.00
Disclosure

SEC source: 0001735276-25-000062 · edgardoc.xml · nonDerivative · entry 4

Reitan Colleen F · CIK 0001740730 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 775

F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:04 UTC GrantStock Option (right to buy) · Derivative 1,558 $0.00 Strike: $258.35 $0.00
Disclosure

SEC source: 0001735276-25-000060 · edgardoc.xml · derivative · entry 3

Sigal Charles Elliott · CIK 0001661908 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,558

Underlying: Common Stock · 1,558 shares

Expires 2035-05-08

F3 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:04 UTC GrantCommon Stock 775 $0.00 $0.00
Disclosure

SEC source: 0001735276-25-000060 · edgardoc.xml · nonDerivative · entry 1

Sigal Charles Elliott · CIK 0001661908 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 775

F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:03 UTC GrantStock Option (right to buy) · Derivative 1,558 $0.00 Strike: $258.35 $0.00
Disclosure

SEC source: 0001735276-25-000059 · edgardoc.xml · derivative · entry 2

Bertozzi Carolyn R · CIK 0001698766 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,558

Underlying: Common Stock · 1,558 shares

Expires 2035-05-08

F2 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:03 UTC GrantCommon Stock 775 $0.00 $0.00
Disclosure

SEC source: 0001735276-25-000059 · edgardoc.xml · nonDerivative · entry 1

Bertozzi Carolyn R · CIK 0001698766 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 775

F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
May 02, 2025 Filed May 6, 2025 21:05 UTC
Greenstreet YvonneDirector · Chief Executive Officer
GiftCommon Stock 41,311 $0.00 $0.00
Disclosure

SEC source: 0001735276-25-000047 · edgardoc.xml · nonDerivative · entry 1

Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,324

F1 · kind: The reported transaction involves a transfer of securities by bona fide gift for estate planning purposes to the Yvonne Greenstreet 2024 Irrevocable Trust Dtd 10/29/2024, of which the reporting person is neither the trustee nor a beneficiary.

Read SEC document
April 16, 2025 Filed May 12, 2025 20:05 UTC SaleCommon Stock 36 $232.86 $8,382.96
Disclosure

SEC source: 0001735276-25-000062 · edgardoc.xml · nonDerivative · entry 3

Reitan Colleen F · CIK 0001740730 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Read SEC document
March 24, 2025 Filed Mar 25, 2025 20:09 UTC Exercise / conversionStock Option (right to buy) · Derivative 7,440 $0.00 Strike: $88.95 $0.00
Disclosure

SEC source: 0001735276-25-000040 · edgardoc.xml · derivative · entry 4

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,440 shares

Expires 2025-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on September 5, 2024. The options exercised and sold by the reporting person were due to expire on December 18, 2025.

F3 · derivative.exercise_date: This stock option was fully vested and exercisable as of December 18, 2016.

Read SEC document
March 24, 2025 Filed Mar 25, 2025 20:09 UTC SaleCommon Stock 7,440 $299.00 $2,224,560.00
Disclosure

SEC source: 0001735276-25-000040 · edgardoc.xml · nonDerivative · entry 2

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 136

F1 · kind: The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on September 5, 2024. The options exercised and sold by the reporting person were due to expire on December 18, 2025.

Read SEC document
March 24, 2025 Filed Mar 25, 2025 20:09 UTC Exercise / conversionCommon Stock 7,440 $88.95 $661,788.00
Disclosure

SEC source: 0001735276-25-000040 · edgardoc.xml · nonDerivative · entry 1

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,576

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on September 5, 2024. The options exercised and sold by the reporting person were due to expire on December 18, 2025.

Read SEC document
March 24, 2025 Filed Mar 25, 2025 20:10 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
Exercise / conversionStock Option (right to buy) · Derivative 5,445 $0.00 Strike: $42.22 $0.00
Disclosure

SEC source: 0001735276-25-000041 · edgardoc.xml · derivative · entry 6

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,445 shares

Expires 2026-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024.

F4 · derivative.exercise_date: This stock option was fully vested and exercisable as of December 20, 2020.

Read SEC document
March 24, 2025 Filed Mar 25, 2025 20:10 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
SaleCommon Stock 5,445 $300.00 $1,633,500.00
Disclosure

SEC source: 0001735276-25-000041 · edgardoc.xml · nonDerivative · entry 3

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,221

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024.

Read SEC document
March 24, 2025 Filed Mar 25, 2025 20:10 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
Exercise / conversionCommon Stock 5,445 $42.22 $229,887.90
Disclosure

SEC source: 0001735276-25-000041 · edgardoc.xml · nonDerivative · entry 2

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024.

Read SEC document
March 21, 2025 Filed Mar 25, 2025 20:10 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
SaleCommon Stock 4,321 $285.00 $1,231,485.00
Disclosure

SEC source: 0001735276-25-000041 · edgardoc.xml · nonDerivative · entry 1

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,221

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024.

Read SEC document
March 13, 2025 Filed Mar 14, 2025 20:16 UTC Exercise / conversionStock Option (right to buy) · Derivative 2,750 $0.00 Strike: $131.21 $0.00
Disclosure

SEC source: 0001735276-25-000037 · edgardoc.xml · derivative · entry 2

SCHULMAN AMY W · CIK 0001438226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,750 shares

Expires 2025-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and held by the reporting person were due to expire on June 1, 2025.

F2 · derivative.exercise_date: The stock option was fully vested as of June 1, 2016.

Read SEC document
March 13, 2025 Filed Mar 14, 2025 20:16 UTC Exercise / conversionCommon Stock 2,750 $131.21 $360,827.50
Disclosure

SEC source: 0001735276-25-000037 · edgardoc.xml · nonDerivative · entry 1

SCHULMAN AMY W · CIK 0001438226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,186

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and held by the reporting person were due to expire on June 1, 2025.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 21:22 UTC
Fitzgerald Kevin JosephCSO & EVP, Head of Research
SaleCommon Stock 71 $242.93 $17,248.03
Disclosure

SEC source: 0001735276-25-000034 · edgardoc.xml · nonDerivative · entry 15

Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,501

F9 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2024.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 21:22 UTC
Fitzgerald Kevin JosephCSO & EVP, Head of Research
SaleCommon Stock 324 $241.68 $78,304.32
Disclosure

SEC source: 0001735276-25-000034 · edgardoc.xml · nonDerivative · entry 14

Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,572

F9 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2024.

F15 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $241.40 to $241.85. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 21:22 UTC
Fitzgerald Kevin JosephCSO & EVP, Head of Research
SaleCommon Stock 328 $240.95 $79,031.60
Disclosure

SEC source: 0001735276-25-000034 · edgardoc.xml · nonDerivative · entry 13

Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,896

F9 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2024.

F14 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $240.18 to $241.17. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 21:22 UTC
Fitzgerald Kevin JosephCSO & EVP, Head of Research
SaleCommon Stock 121 $239.24 $28,948.04
Disclosure

SEC source: 0001735276-25-000034 · edgardoc.xml · nonDerivative · entry 12

Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,224

F9 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2024.

F13 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $238.93 to $239.40. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 21:21 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
SaleCommon Stock 120 $242.70 $29,124.00
Disclosure

SEC source: 0001735276-25-000032 · edgardoc.xml · nonDerivative · entry 15

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,542

F10 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024.

F17 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $242.46 to $242.93. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 21:21 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
SaleCommon Stock 198 $241.60 $47,836.80
Disclosure

SEC source: 0001735276-25-000032 · edgardoc.xml · nonDerivative · entry 14

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,662

F10 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024.

F16 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $241.21 to $242.02. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 21:21 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
SaleCommon Stock 343 $240.92 $82,635.56
Disclosure

SEC source: 0001735276-25-000032 · edgardoc.xml · nonDerivative · entry 13

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,860

F10 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024.

F15 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $240.18 to $241.17. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 21:21 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
SaleCommon Stock 147 $239.25 $35,169.75
Disclosure

SEC source: 0001735276-25-000032 · edgardoc.xml · nonDerivative · entry 12

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,203

F10 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024.

F14 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $238.93 to $239.40. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:23 UTC
Hesslein Robert W.EVP, CLO and Secretary
GrantStock Option (right to buy) · Derivative 1,529 $0.00 Strike: $243.53 $0.00
Disclosure

SEC source: 0001735276-25-000035 · edgardoc.xml · derivative · entry 2

Hesslein Robert W. · CIK 0001585018 · EVP, CLO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,529

Underlying: Common Stock · 1,529 shares

Expires 2035-03-03

F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the grant date and the remaining shares vest in equal installments at the end of each successive three-month period thereafter until the fourth anniversary of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:23 UTC
Hesslein Robert W.EVP, CLO and Secretary
GrantCommon Stock 757 $0.00 $0.00
Disclosure

SEC source: 0001735276-25-000035 · edgardoc.xml · nonDerivative · entry 1

Hesslein Robert W. · CIK 0001585018 · EVP, CLO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,002

F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest over a three-year period, with one third vesting on each of the first, second and third anniversaries of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:22 UTC
Fitzgerald Kevin JosephCSO & EVP, Head of Research
GrantStock Option (right to buy) · Derivative 7,819 $0.00 Strike: $243.53 $0.00
Disclosure

SEC source: 0001735276-25-000034 · edgardoc.xml · derivative · entry 17

Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,819

Underlying: Common Stock · 7,819 shares

Expires 2035-03-03

F17 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the grant date and the remaining shares vest in equal installments at the end of each successive three-month period thereafter until the fourth anniversary of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.